Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan-Reference-Cited by-同舟云学术

Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan

Published:2023-11-07 Issue:12 Volume:62 Page:1979-1982
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Mau-Sørensen Morten¹,Gerner-Rasmussen Jonas¹,Hansen Olfred²^ORCID,Holm Bente³,Nyhus Christa Haugaard⁴,McCulloch Tine⁵,Nielsen Henrik Anker⁶,Wedervang Kim⁷,Rytter Carsten⁸,Jeppesen Nina⁹,Langer Seppo W.¹¹⁰^ORCID

Affiliation:

1. Department of Oncology, Copenhagen University Hospital—Rigshospitalet, Copenhagen, Denmark

2. Department of Oncology, Odense University Hospital, Odense, Denmark

3. Department of Oncology, Copenhagen University Hospital—Herlev, Copenhagen, Denmark

4. Department of Oncology, Lillebaelt Hospital, Denmark

5. Department of Oncology, Aalborg University Hospital, Denmark

6. Department of Oncology, Hilleroed Hospital, Denmark

7. Department of Oncology, Naestved Hospital, Naestved, Denmark

8. Department of Oncology, Aarhus University Hospital, Denmark

9. Department of Oncology, Zealand University Hospital, Denmark

10. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Publisher

Medical Journals Sweden AB

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2023.2278173

Reference16 articles.

1. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

2. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

3. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

4. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent

5. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial.